Skin cancer is the most common type of cancer in both men and women in the United States. There are several kinds of skin cancer including squamous cell, basal cell, Merkel cell and melanoma. Melanoma is the most serious form of skin cancer. Unlike basal and squamous cell carcinomas, melanoma of the skin has tendency to spread outside the skin to other organs. Melanoma incidence has been rising over the past few decades.
The University of Arizona Cancer Center is the only Comprehensive Cancer Center (designated by the National Cancer Institute) in the state of Arizona and provides cutting edge research and treatment options for melanoma not yet available as standard of care.
Our Melanoma Team is a clinical research team that include medical oncologists, surgical oncologists, radiation oncologists, interventional radiologists, dermatologists, clinical and regulatory research coordinators, and clinical and research nurses. Our oncologists have extensive experience with the growing array of precision cancer treatments for melanoma.
We have a portfolio of clinical trials utilizing novel immune and targeted therapies for different stages of melanoma that provide options for variable patient conditions including refractory cases. Our trial list changes continuously and gets updated at our trial website.
We will be happy to meet any patient in person and discuss their unique circumstance.
Clinical Research Nursing
Clinical Research Coordination
Research Data Coordination
U.S. Preventive Services Task Force calls for more research on skin cancer screening
University of Arizona Cancer Center member and member of the U.S. Preventive Services Task Force, John Ruiz, PhD, co-authored the Task Force’s final recommendation on screening for skin cancer, which was released today.
Melanoma Walk/Run 2022 Will be Held on University of Arizona Mall
UArizona Skin Cancer Institute Presents 11th Annual Melanoma Walk
The only National Cancer Institute-designated Comprehensive Cancer Center headquartered in the state of Arizona.
Bringing promising new therapies from the laboratory to the bedside is a high priority. The clinician scientists of the University of Arizona Cancer Center are engaged in more than 200 clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies.